News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
90 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (92)
2 (55)
3 (1)
4 (4)
5 (65)
6 (116)
7 (86)
8 (101)
9 (46)
10 (4)
11 (5)
12 (90)
13 (97)
14 (81)
15 (116)
16 (43)
17 (1)
18 (12)
19 (98)
20 (90)
21 (83)
22 (111)
23 (47)
26 (66)
27 (70)
28 (93)
29 (55)
30 (39)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
26
27
28
29
30
31
BioCapital
GlycoMimetics Announces Pricing of Public Offering of Common Stock At $17 Per Share
GlycoMimetics, Inc. announced the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $17.00 per share.
March 20, 2018
·
2 min read
Drug Development
Antibe Therapeutics Announces Successful Phase 2B Gastrointestinal Safety Study for Lead Pain Drug, ATB-346
The double-blind study was conducted in 244 healthy volunteers and was designed to demonstrate the superiority of ATB-346 in GI safety compared to naproxen.
March 20, 2018
·
6 min read
FDA
Exactech’s Vitamin E Acetabular Polyethylene Liner for Hip Replacement Gains FDA 510(k) Clearance
Clearance from the U.S. Food and Drug Administration (FDA) to market the Novation XLE Vitamin E acetabular polyethylene liners for hip replacement surgery.
March 20, 2018
·
1 min read
Policy
U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions
Patent protects a new category of innovative drug delivery systems New patent is the second granted to BioPharmX in 3 weeks
March 20, 2018
·
5 min read
Business
Monsanto and Pairwise Announce R&D Collaboration to Accelerate Innovation in Agriculture with Gene Editing
Partners’ Leading Expertise And The Potential Of Base Editing To Fuel Advancement
March 20, 2018
·
7 min read
Business
Global Alzheimer’s Platform (GAP) Foundation Launches Partnership with Lyft to Transport Clinical Trial Participants to and from Clinical Research Facilities across North America
Lyft drivers will transport clinical trial participants to and from GAP-Net research sites
March 20, 2018
·
7 min read
Pharm Country
Contagion® Outbreak Monitor Keeps Doctors Up-to-date on Recent Multistate Outbreak of Salmonella Infections
The outbreak has been linked to kratom, an opioid substitute
March 20, 2018
·
2 min read
Business
Progress Continues for PrescribeIT
New EMR and PMS vendors on board with Canada’s national e-prescribing service
March 20, 2018
·
2 min read
BioForest
New Report Shows States Fall Short on Policies to Help Reduce Burden of Rare Diseases Affecting 1 in 10 Americans
A majority of states are not measuring up on legislative solutions that reduce the burden of rare diseases affecting 30 million Americans, according to a new report released today by the National Organization for Rare Disorders Rare Action Network™ (NORD RAN).
March 20, 2018
·
3 min read
Biotech Bay
Pivot Bio Announces Pre-Commercial Launch of Nitrogen-Producing Microbes to Improve Crop Nutrition and Yields
Large-plot beta testing across the Corn Belt will validate Pivot Bio’s first-to-market, commercial-scale microbes
March 20, 2018
·
2 min read
Previous
4 of 9
Next